Rakesh Kumar
ORCIDPublication Activity (10 Years)
Years Active: 2020-2023
Publications (10 Years): 7
Publications (10 Years): 7
Publications
- Tina Cascone, Gozde Kar, Jonathan D Spicer, María Del Rosario García-Campelo, Walter Weder, Davey B Daniel, David R Spigel, Maen Hussein, Julien Mazieres, Júlio Oliveira, Edwin H Yau, Alexander I Spira, Valsamo Anagnostou, Raymond Mager, Oday Hamid, Lin-Yang Cheng, Ying Zheng, Jorge M Blando, Tze Heng Tan, Michael Surace, Jaime Rodriguez-Canales, Vancheswaran Gopalakrishnan, Bret R Sellman, Italia Grenga, Yee Soo-Hoo, Rakesh Kumar, Lara McGrath, Patrick M Forde
- Johanna Bendell, Patricia LoRusso, Michael James Overman, Anne M Noonan, Dong Wan Kim, John H Strickler, Sang-We Kim, Stephen Clarke, Thomas J George, Peter S Grimison, Minal Barve, Manik Amin, Jayesh Desai, Trisha Michel Wise-Draper, Steven Eck, Yu Jiang, Anis A Khan, Yuling Wu, Philip Martin, Zachary A Cooper, Nairouz Elgeioushi, Nancy Mueller, Rakesh Kumar, Sandip Pravin Patel
- Emerson A Lim, Johanna C Bendell, Gerald S Falchook, Todd M Bauer, Charles G Drake, Jennifer H Choe, Daniel J George, Janet L Karlix, Susanna V Ulahannan, Kris F Sachsenmeier, Deanna L Russell, Ganesh Moorthy, Ben S Sidders, Elizabeth A Pilling, Huifang Chen, Maureen M Hattersley, Mayukh Das, Rakesh Kumar, Gayle P Pouliot, Manish R Patel
- Charu Aggarwal, Nabil F Saba, Alain Patrick Algazi, Ammar Sukari, Tanguy Y Seiwert, Missak Haigentz, Mercedes Porosnicu, Marcelo Bonomi, Jean Boyer, Mark T Esser, Lily I Cheng, Sonia Agrawal, Emily C Jennings, Nicholas M Durham, Karl Fraser, Delphine Lissa, Maozhen Gong, Natalia Ceaicovscaia, Amaya Gasco Hernandez, Rakesh Kumar
- Roy S Herbst, Margarita Majem, Fabrice Barlesi, Enric Carcereny, Quincy Siu-Chung Chu, Isabelle Monnet, Alfredo Sánchez, Shaker Dakhil, D Ross Camidge, Leanne Winzer, Yee Soo-Hoo, Zachary A Cooper, Rakesh Kumar, John Bothos, Charu Aggarwal, Alex Martinez-MartiCOAST: An Open-Label, Phase II, Multidrug Platform Study of Durvalumab Alone or in Combination With Oleclumab or Monalizumab in Patients With Unresectable, Stage III Non-Small-Cell Lung Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (29) (2022)
- Ani S Balmanoukian, Jeffrey R Infante, Raid Aljumaily, Aung Naing, Ashish V Chintakuntlawar, Naiyer A Rizvi, Helen J Ross, Michael Gordon, Philip R Mallinder, Nairouz Elgeioushi, Ignacio González-García, Nathan Standifer, Jennifer Cann, Nicholas Durham, Shahram Rahimian, Rakesh Kumar, Crystal S Denlinger